A prospectively planned pathology study within the TEAM trial confirms that progesterone receptor expression is prognostic but is not predictive for differential response to exemestane versus tamoxifen.

J. M. S. Bartlett, C. L. Brookes, L. J. Billingham, F. M. Campbell, M. Grant, A. Hasenburg, E. T. M. Hille, C. Kay, D. Kieback, C. Markopoulos, E. M-K Kranenbarg, E. A. Mallon, R. Paridaens, T. Robson, C. Seynaeve, C. J. H. van de Velde, D. Rea

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)83S-83S
Number of pages1
JournalCancer Research
Issue number2
Publication statusPublished - 15 Jan 2009

Cite this